Comparing two blood thinners during continuous dialysis
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study compares two blood-thinning medications used during continuous dialysis for acute kidney injury: one uses citrate (a chemical that prevents clotting) and the other uses heparin (a standard blood thinner). By looking at how well these treatments work, the study aims to find the safest and most effective way to keep the dialysis filter working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child's legal guardian must sign a consent form agreeing to participate.
- The patient must be at least 18 years old (or a child with parental consent, but must weigh at least 8 kg or about 17.6 pounds).
- The patient must have acute kidney injury (sudden kidney failure) and a doctor's recommendation for continuous kidney replacement therapy (a form of dialysis).
- The patient must be expected to live longer than 3 days, as judged by the doctor.
- Participants cannot have uncontrolled bleeding or blood clotting problems, and cannot have joined another interventional study in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to prevent blood clots during kidney dialysis in people with sepsis-related kidney failure. The goal is to see which method is safer and works better to keep the dialysis filter working properly.
This study compares two ways to prevent blood from clotting during a type of dialysis called hemodiafiltration. You may get either a standard drug (heparin) or a newer approach using citrate to keep your dialysis filter from clotting.
This trial compares two types of dialysis (hemodialysis and hemodiafiltration) to see which is better at removing waste from the blood in ICU patients with sudden kidney failure. It may help doctors choose the best treatment for you.
This study compares two methods for removing waste products from the blood in people who need dialysis. It aims to see whether one method works better or is safer during extra-renal (outside the body) blood purification.
This study tests whether a specific blood-thinning method using citrate works safely and effectively in critically ill patients whose kidneys have suddenly stopped working and need a special filtering machine. Researchers want to confirm that this approach prevents dangerous blood clots while keeping patients safe.
This study compares two ways of changing the filter in the dialysis machine for people with severe acute kidney injury in the intensive care unit. It looks at whether changing the filter more often (standard) is better or worse than leaving it in longer (shorter filter lifespan).
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.